Potential impact of COVID ‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study-Reference-Cited by-同舟云学术

Potential impact of COVID ‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study

Published:2021-02-16 Issue:3 Volume:20 Page:675-691
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Lasch Florian¹^ORCID,Guizzaro Lorenzo²³^ORCID,Aguirre Dávila Lukas⁴,Müller‐Vahl Kirsten¹,Koch Armin¹^ORCID

Affiliation:

1. Hannover Medical School Hannover Germany

2. European Medicines Agency Amsterdam Netherlands

3. Università della Campania Naples Italy

4. Paul‐Ehrlich‐Institut Langen Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2100

Reference30 articles.

1. Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic

2. Clinical trials impacted by the COVID‐19 pandemic: adaptive designs to the rescue?;Kunz CU;Stat Biopharm Res,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible data-generating models of longitudinal continuous outcomes and intercurrent events to investigate estimands;Statistics in Biopharmaceutical Research;2024-06-26

2. “Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”;Human Vaccines & Immunotherapeutics;2023-11-09

3. Estimators for handling COVID ‐19‐related intercurrent events with a hypothetical strategy;Pharmaceutical Statistics;2022-06-28

4. The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United States;Clinical Pharmacology & Therapeutics;2022-02-17